IWM
ABCL icon

IMG Wealth Management’s AbCellera Biologics ABCL Stock Holding History

IMG Wealth Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,000
Closed -$42.4K – 485
2025
Q1 		$42.4K Hold
19,000
– – 0.04% 154
2024
Q4 		$55.7K Buy
+19,000
New +$52.9K 0.05% 135

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IMG Wealth Management's ABCL Position: Q2 2025 in Review

IMG Wealth Management sold out of AbCellera Biologics (ABCL) in Q2 2025, closing a stake of 19,000 shares — an estimated $42.4K sold.

IMG Wealth Management first reported a position in ABCL in Q4 2024 and held it in 2 quarters. The position peaked at $55.7K in Q4 2024. 128 funds tracked by Wall St. Rank hold ABCL as of Q2 2025.

  • IMG Wealth Management reported no remaining AbCellera Biologics position as of Q2 2025 after selling out during the quarter.
  • IMG Wealth Management sold 19,000 AbCellera Biologics shares in Q2 2025, an estimated $42.4K.
  • IMG Wealth Management first reported a position in AbCellera Biologics in Q4 2024 and held it in 2 quarters.
  • IMG Wealth Management's AbCellera Biologics position peaked at $55.7K in Q4 2024.
  • 128 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2025.

Based on IMG Wealth Management's 13F filing for Q2 2025, filed 30 Jul 2025.